Article Figures & Data
Figures
- Figure 1.
The correlation between the tumor proportion score by 22C3 and 28-8 staining assays for programmed cell death ligand 1. Kendall's rank correlation coefficient was 0.8414.
- Figure 2.
Nanogram based on multivariate analysis developed for overall survival of patients after starting nivolumab therapy. To use this nomogram, a vertical line is drawn upward to the Points bar is used to identify the points for each. Based on the sum of the points, a line is drawn vertically downward from the Total points bar to calculate the hazard ratio (HR). Points were assigned from the Points scale according to the following factors: Baseline age: from 25 years old; sex: female 0, male 1; EGFR mutation: none 0, present 1; histology: adenocarcinoma 1, squamous 2, other 3; PS: PS 0-1 0, PS 2-4 1; stage: other (stage III, recurrence after surgery) 0, stage IV 1; smoking history: none 0, 1 positive; LDH, according to LDH level (U/l); ALI: according to the ALI score; steroid use: none 0, present 1; Liver: no liver metastasis 0, liver metastasis 1; last response: not progressive disease 0, progressive disease 1; IHC 22C3, programmed cell death ligand 1 staining: unknown/0% 0, 1-49% 1, >50% 2.
